Literature DB >> 33548580

The receptor for advanced glycation end products mediates dysfunction of airway epithelial barrier in a lipopolysaccharides-induced murine acute lung injury model.

Jiahui Li1, Kai Wang2, Bo Huang2, Rui Li1, Xilong Wang1, Hailing Zhang1, Haixiong Tang3, Xin Chen4.   

Abstract

BACKGROUND: Airway epithelial cells (AECs) act as the first barrier protecting against invasion of environment agents and maintain integrity of lung structure and function. Dysfunction of airway epithelial barrier has been shown to be involved in ALI/ARDS pathogenesis. Yet, the exact mechanism is still obscure. Our study evaluated whether the receptor for advanced glycation end products (RAGE) mediates impaired airway epithelial barrier in LPS-induced murine ALI model.
METHODS: Male BALB/c mice were subjected to intratracheal instillation of LPS to generate an ALI model. Inhibitors of RAGE, FPS-ZM1 and Azeliragon were respectively given to the mice through intraperitoneal injection. Bronchoalveolar lavage fluid (BALF) and lung tissues were collected for further analysis.
RESULTS: LPS exposure led to markedly increased expression of RAGE and its ligands HMGB1, HSP70, S100b. Treatment of FPS-ZM1 or Azeliragon not only effectively descended the expression of RAGE and its ligands but also attenuated LPS-induced neutrophil-predominant airway inflammation and injury, decreased levels of IL-6, IL-1β and TNF-α in BALF, alleviated increased alveolar-capillary permeability and pulmonary edema. LPS stimulation significantly impaired the integrity of airway epithelium, paralleled with dislocation of adheren junction (AJ) protein E-cadherin at cell-cell contacts and down-expression of both AJ and tight junction (TJ) proteins Claudin-2 and occludin, all of which were dramatically rescued by RAGE inhibition.
CONCLUSION: RAGE signaling mediates airway epithelial barrier dysfunction in a LPS-induced ALI murine model.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Acute lung injury; Adherens junctions; Airway epithelial barrier; RAGE; Tight junctions

Mesh:

Substances:

Year:  2021        PMID: 33548580     DOI: 10.1016/j.intimp.2021.107419

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

Review 1.  Tight Junctions, the Epithelial Barrier, and Toll-like Receptor-4 During Lung Injury.

Authors:  Nachiket M Godbole; Asif Alam Chowdhury; Neha Chataut; Shanjana Awasthi
Journal:  Inflammation       Date:  2022-07-02       Impact factor: 4.657

Review 2.  Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease.

Authors:  Seigmund Wai Tsuen Lai; Edwin De Jesus Lopez Gonzalez; Tala Zoukari; Priscilla Ki; Sarah C Shuck
Journal:  Chem Res Toxicol       Date:  2022-10-05       Impact factor: 3.973

3.  Syndecan-1 Shedding by Matrix Metalloproteinase-9 Signaling Regulates Alveolar Epithelial Tight Junction in Lipopolysaccharide-Induced Early Acute Lung Injury.

Authors:  Dong Zhang; Jin-Tao Zhang; Yun Pan; Xiao-Fei Liu; Jia-Wei Xu; Wen-Jing Cui; Xin-Rui Qiao; Liang Dong
Journal:  J Inflamm Res       Date:  2021-11-04

4.  Methylglyoxal Exacerbates Lipopolysaccharide-Induced Acute Lung Injury via RAGE-Induced ROS Generation: Protective Effects of Metformin.

Authors:  Matheus L Medeiros; Akila L Oliveira; Mariana G de Oliveira; Fabíola Z Mónica; Edson Antunes
Journal:  J Inflamm Res       Date:  2021-12-02

5.  Receptor for Advanced Glycation End-Products Promotes Activation of Alveolar Macrophages through the NLRP3 Inflammasome/TXNIP Axis in Acute Lung Injury.

Authors:  Woodys Lenga Ma Bonda; Marianne Fournet; Ruoyang Zhai; Jean Lutz; Raiko Blondonnet; Céline Bourgne; Charlotte Leclaire; Cécile Saint-Béat; Camille Theilliere; Corinne Belville; Damien Bouvier; Loïc Blanchon; Marc Berger; Vincent Sapin; Matthieu Jabaudon
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.